Investigative Urology
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer - Abstract
September 21, 2012
PKD2 and PKD3 promote prostate cancer cell invasion via uPA by shifting balance between NF-κB and HDAC1 - Abstract
September 21, 2012
3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells - Abstract
September 21, 2012
Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition - Abstract
September 20, 2012
Expression and role of HMGA1 in renal cell carcinoma - Abstract
September 20, 2012
High-level expression of Notch1 increased the risk of metastasis in T1 stage clear cell renal cell carcinoma - Abstract
September 20, 2012
VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma - Abstract
September 20, 2012
Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma - Abstract
September 19, 2012
Synergistic and selective cancer cell killing mediated by the oncolytic adenoviral mutant Ad∆∆ and dietary phytochemicals in prostate cancer models - Abstract
September 19, 2012
Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents - Abstract
September 19, 2012
The effect of culture conditions on colony morphology and proliferative capacity in human prostate cancer cell lines - Abstract
September 19, 2012
c-Myc expression and MEK1 induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer - Abstract
September 19, 2012
Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract Infections in mice - Abstract
September 18, 2012